Chronic hepatitis E and hepatitis E seroprevalence in immunosuppressed patients: a prospective study
HEV IgG seroprevalence in our immunosuppressed population is 9.9%. Chronic HEV was found in 0.6% of the patients, all kidney transplanted and having required ribavirin treatment.
Authors
- Michael Peeters (ORCID: https://orcid.org/0000-0002-0775-7888)
- Sophie Lamoral
- Marina Mukovnikova
- Xavier Poiré (ORCID: https://orcid.org/0000-0003-1897-0227)
- Alexandra Vodolazkaia (ORCID: https://orcid.org/0000-0002-1820-4541)
- Géraldine Dahlqvist (ORCID: https://orcid.org/0000-0002-4661-7650)
- Sarah Bailly (ORCID: https://orcid.org/0000-0001-9363-267X)
- Arnaud Devresse (ORCID: https://orcid.org/0000-0003-4943-788X)
- Nada Kanaan (ORCID: https://orcid.org/0000-0001-7903-8631)
- Hubert Piessevaux (ORCID: https://orcid.org/0000-0003-1193-0601)
- Benoît Kabamba
- Maria Chiara Badii
- Marie Philippart (ORCID: https://orcid.org/0009-0008-5041-7660)
Institutions
- Cliniques Universitaires Saint-Luc (BE)
- UCLouvain Saint-Louis Brussels (BE)
- Sciensano (Belgium) (BE)
Publication Details
- Journal
- Translational Gastroenterology and Hepatology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/tgh-24-154
- Primary Topic
- Hepatitis Viruses Studies and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00